Antibodies to amyloid beta

However, overproduction or changes in A? levels are believed to be key events in the pathogenesis of sporadic and early onset AD. For this reason, A? has become a major target for the development of drugs designed to reduce its formation (Vassar et al., 1999), or to activate mechanisms that …